Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...
Read Full NewsRegenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy could support an accelerated approval application, reversing course...
Researchers conducted a systematic review of 441 US-based randomized cancer treatment trials to see what patient characteristics were reported.
The University of Nebraska Medical Center said on Monday all 18 U.S.-resident passengers from the hantavirus-hit cruise ship MV Hondius have returned to their home states...
French authorities urge clinicians to consider synthetic cannabinoid exposure in adolescents presenting with unexplained neurologic, psychiatric, or cardiovascular symptoms.
Vericiguat may be beneficial for heart failure with reduced ejection fraction, according to a new study that accounted for mortality events occurring after heart failure hospitalization.
Fewer than 1 in 4 patients with stroke and fewer than 1 in 7 with traumatic brain injury are discharged from the hospital to an inpatient rehabilitation facility, new data show.
New findings suggest the heart’s mechanical activity actively restrains tumor growth, revealing a pathway that could inspire future cancer treatments.
1.
Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer
2.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
3.
Mezigdomide Combinations Show Promise in Multiple Myeloma
4.
Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.
5.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
1.
Obesity is a major risk factor for cancer
2.
The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium
3.
Emerging Advances in Hematology and Quality Improvement
4.
LncRNAs in Cancer: Shaping Tumor Progression & Paving New Paths for Treatment
5.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge